Yili Chen

768 total citations
38 papers, 497 citations indexed

About

Yili Chen is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yili Chen has authored 38 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yili Chen's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (3 papers). Yili Chen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (3 papers). Yili Chen collaborates with scholars based in China, United States and New Zealand. Yili Chen's co-authors include Eleftherios T. Papoutsakis, Dinesh C. Indurthi, Shawn W. Jones, Weihong Wang, Kai Chang, Qiong Wan, Budbazar Enkhjargal, Zachary D. Travis, Jianhua Peng and Tongyu Zhang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Yili Chen

35 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yili Chen China 11 178 75 58 55 46 38 497
Ya Su China 19 775 4.4× 110 1.5× 40 0.7× 40 0.7× 27 0.6× 56 1.2k
Andrea Coppola Italy 15 229 1.3× 14 0.2× 245 4.2× 97 1.8× 21 0.5× 39 787
Yanhong Yang China 19 316 1.8× 8 0.1× 113 1.9× 60 1.1× 22 0.5× 54 769
Xuejiao Zhang China 18 412 2.3× 9 0.1× 61 1.1× 34 0.6× 15 0.3× 58 893
Hà Thị Thu Vietnam 11 101 0.6× 14 0.2× 130 2.2× 76 1.4× 5 0.1× 31 523
Kaiwen Wu China 12 216 1.2× 9 0.1× 71 1.2× 5 0.1× 19 0.4× 50 475
Xinyu Ma China 15 316 1.8× 8 0.1× 102 1.8× 8 0.1× 21 0.5× 58 635

Countries citing papers authored by Yili Chen

Since Specialization
Citations

This map shows the geographic impact of Yili Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yili Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yili Chen more than expected).

Fields of papers citing papers by Yili Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yili Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yili Chen. The network helps show where Yili Chen may publish in the future.

Co-authorship network of co-authors of Yili Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yili Chen. A scholar is included among the top collaborators of Yili Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yili Chen. Yili Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yili, Zhanwei Liu, Shuting Cai, et al.. (2025). Bifunctional additive engineering in quasi-2D perovskites for efficient and stable blue light-emitting diodes via phase modulation and defect passivation. Journal of Luminescence. 282. 121253–121253.
2.
Zhang, Jianfeng, Ziyi Ding, Xinhui Liu, et al.. (2024). Stable, Scalable, and Free-Standing Perovskite Quantum Dots Composite Reinforced by Cellulose Fibers. ACS Applied Materials & Interfaces. 16(28). 36811–36820. 3 indexed citations
3.
Wang, Yongmei, Yili Chen, Hui Xu, et al.. (2024). Comparison of “framework Shuffling” and “CDR Grafting” in humanization of a PD-1 murine antibody. Frontiers in Immunology. 15. 1395854–1395854. 4 indexed citations
4.
Yang, Xi, Wenyan Yu, Jiali Zhang, et al.. (2024). Discovery of aurovertin B as a potent metastasis inhibitor against triple-negative breast cancer: Elucidating the complex role of the ATF3-DUSP1 axis. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100005–100005. 4 indexed citations
5.
Chen, Yili, et al.. (2024). Natural product-derived ferroptosis mediators. Phytochemistry. 219. 114002–114002. 12 indexed citations
6.
Chen, Yili, et al.. (2024). A prospective therapeutic strategy: GPX4-targeted ferroptosis mediators. European Journal of Medicinal Chemistry. 281. 117015–117015. 6 indexed citations
7.
8.
Wang, Linkai, et al.. (2023). Bilateral Transient Dilated and Fixed Pupils After Microvascular Decompression: Rare Clinical Experience. Journal of Craniofacial Surgery. 34(4). 1296–1300. 1 indexed citations
9.
Chen, Yili, Jianzhong Li, Dongxiang Luo, Zhe Fu, & Xiaoming Xiong. (2023). DOA estimation for uniform circular array without the source number based on beamspace transform and higher-order cumulant. Physical Communication. 59. 102121–102121. 1 indexed citations
10.
Chen, Yili, Yuchen Chen, Tingting Gong, et al.. (2023). Discovery of phenylcarbamoyl xanthone derivatives as potent neuroprotective agents for treating ischemic stroke. European Journal of Medicinal Chemistry. 251. 115251–115251. 12 indexed citations
11.
Cheng, Chun‐Chia, et al.. (2022). Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8+ T cell activation to eradicate hepatocellular carcinoma. International Immunopharmacology. 112. 109110–109110. 22 indexed citations
12.
Chen, Yili, et al.. (2021). Environmental Regulation,Market Power and Enterprise Innovation. 39(1). 30. 1 indexed citations
13.
Chen, Yuning, Yanan Zhang, Renhong Yan, et al.. (2021). ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduction and Targeted Therapy. 6(1). 315–315. 38 indexed citations
14.
Li, Kaiqiang, Lingling Wu, Yili Chen, et al.. (2020). <p>Cytotoxic and Antiproliferative Effects of β-Mangostin on Rat C6 Glioma Cells Depend on Oxidative Stress Induction via PI3K/AKT/mTOR Pathway Inhibition</p>. Drug Design Development and Therapy. Volume 14. 5315–5324. 20 indexed citations
15.
Mo, Jun, Budbazar Enkhjargal, Zachary D. Travis, et al.. (2018). AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats. Redox Biology. 20. 75–86. 132 indexed citations
16.
Zheng, Haiyan, et al.. (2018). A rare case of deep cerebral venous thrombosis secondary to traumatic epidural hematoma. Medicine. 97(36). e11587–e11587. 2 indexed citations
17.
Gao, Liansheng, et al.. (2017). A rare case of angiosarcoma with skull masses and erythropenia and thrombocytopenia. Medicine. 96(49). e8787–e8787. 2 indexed citations
18.
Chen, Yili, et al.. (2014). GW25-e1596 Nonpeptide angiotensin- (1-7) analogue AVE 0991 modulates proliferation of cardiac fibroblast via regulating Smad pathways. Journal of the American College of Cardiology. 64(16). C75–C76. 1 indexed citations
19.
Guo, Huachun, et al.. (2007). Relationship between SPAD readings chlorophyll contents and yield of potato(Solanum tubersosum L.). Xi'nan nongye xuebao. 20(4). 690–693. 2 indexed citations
20.
Chen, Yili. (2005). Applying 3,5-dinitrosalicylic Acid(DNS) Method to Analyzing the Content of Potato Reducing Sugar. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026